@article{article, title = {{MCL-509 Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)}}, publisher = {{Elsevier BV}}, url = {{http://dx.doi.org/10.1016/s2152-2650(24)01602-1 }}, year = {{2024}}, month = {{9}}, author = {{Shah B and Challagulla S and Xu S and Williams R and Ren S and Srivastava T and Gautam R and Yang K}}, doi = {{10.1016/s2152-2650(24)01602-1}}, volume = {{24}}, journal = {{Clinical Lymphoma Myeloma and Leukemia}}, pages = {{S516-S517}}, note = {{Accessed on 2025/05/22}}}